Home
Issues
Aim & Scope
Editorial Board
Open Access
Indexing
Why publish with us
Contact us
Manuscript Types
Instructions to Authors (PDF)
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Data Policies
Publication Ethics and Publication Malpractice Statement
Crossmark
Supporting Diversity
Special Issue
Bionanotox: Symposium of Bio Nano-Toxicology Pre-Conference Meeting Supplement 2/2022 vol. 2
Pre-Conference Webinar of the 13th International Conference on Biomaterials and Nano-biomaterials
CONFERENCE PROCEEDING
Development of micellar approach for inhibition analysis of galactonolactone oxidase from Trypanosoma cruzi
Public Health Toxicol 2022;2(Supplement Supplement 2):A1
CONFERENCE PROCEEDING
The effect of antifibrotic and antibacterial drugs on the physicochemical properties of liposomes: A spectral study
Irina M. Le-Deygen, Anastasia S. Safronova, Polina V. Mamaeva, Anna A. Skuredina, Elena V. Kudryashova
Public Health Toxicol 2022;2(Supplement Supplement 2):A2
CONFERENCE PROCEEDING
Development of molecular containers based on polyethylenimines, cyclodextrins, spermine and mannose for targeted delivery to alveolar macrophages of fluoroquinolone-based formulations combined with essential oils
Public Health Toxicol 2022;2(Supplement Supplement 2):A3
CONFERENCE PROCEEDING
Preparation methods and biocatalytic properties of covalent conjugates of rhodospirillum rubrum l-asparaginase
Public Health Toxicol 2022;2(Supplement Supplement 2):A4
CONFERENCE PROCEEDING
Fluorescence polarization immunoassay for microcystin-lr
Public Health Toxicol 2022;2(Supplement Supplement 2):A5
CONFERENCE PROCEEDING
Development of fluorescence polarization immunoassay to detect dibutylphthalate (dbp) and its active metabolite monobutylphthalate (mbp) in environmental samples
Public Health Toxicol 2022;2(Supplement Supplement 2):A6
CONFERENCE PROCEEDING
Magnetic nanoparticles in combination with a non-heating low-frequency alternating magnetic field can increase the lysis of E. coli cells under the action of bacteriophage lys394 endolysin
A. D. Usvaliev, N. G. Belogurova, D. Yu. Golovin, A. V. Finko, E. A. Zaitseva, K. A. Miroshnikov, Yu. I. Golovin, N. L. Klyachko
Public Health Toxicol 2022;2(Supplement Supplement 2):A7
CONFERENCE PROCEEDING
Tunable synthetic polymeric scavengers for toxic xenobiotics
Public Health Toxicol 2022;2(Supplement Supplement 2):A8
CONFERENCE PROCEEDING
Nanoparticles based on polyferylic and polygentisic acids as new carriers of anticancer drugs
I. V. Smirnov, A. V. Lisov, A. N. Zvonarev, N. E. Suzina, A. S. Kazakov, Elena Markvicheva, M. Y. Zemskova
Public Health Toxicol 2022;2(Supplement Supplement 2):A9
CONFERENCE PROCEEDING
Matrices from chitosan/oligolactide copolymers with osteoinductive properties for regenerative medicine
Public Health Toxicol 2022;2(Supplement Supplement 2):A10
CONFERENCE PROCEEDING
Fibroin cryostructures cross-linked with genipin for tissue engineering: Preparation and in vitro evaluation
Public Health Toxicol 2022;2(Supplement Supplement 2):A11
CONFERENCE PROCEEDING
Enzymatic copolymerization of aniline and 3-aminobenzoic acid in a deep eutectic solvent
Olga V. Morozova, Irina S. Vasil’eva, Galina P. Shumakovich, Elena A. Zaitseva, Alexander I. Yaropolov
Public Health Toxicol 2022;2(Supplement Supplement 2):A12
CONFERENCE PROCEEDING
Development of nanocontainers for the delivery of 2,4-dinitrophenol derivatives to the liver in the treatment of non-alcoholic fatty liver disease and type 2 diabetes
A. B. Trusova, P. V. Ostroverhov, Maxim A. Abakumov, Vladimir P. Chekhonin, Ksenia Yu. Vlasova, Natalia L. Klyachko
Public Health Toxicol 2022;2(Supplement Supplement 2):A13
CONFERENCE PROCEEDING
Stability study of copper antitumor coordination compound loaded into liposomes
Public Health Toxicol 2022;2(Supplement Supplement 2):A14
CONFERENCE PROCEEDING
Synthesis and characterization of a bifunctional platform based on magnetite-gold nanoparticles for theranostics of cancer
Public Health Toxicol 2022;2(Supplement Supplement 2):A15
CONFERENCE PROCEEDING
Development and evaluation of asgpr-targeted atorvastatin derivatives
Public Health Toxicol 2022;2(Supplement Supplement 2):A16
| ISSN: | 2732-8929 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
